IL1B and acute respiratory distress syndrome: Since visfatin regulates pro-inflammatory activities through release of inflammatory cytokines, including interleukin1-β (IL1-β, interleukin-6(IL-6), and tumor necrosis factor-α (TNF-α [28,35], we studied the correlation of visfatin with pro-inflammatory cytokines in ALI patients.